13F Holdings
中文EN

FOCL EDAP TMS SA

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1041934 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin44.4%
Operating margin-31.8%
Net margin-42.8%
FCF margin—
EBITDA margin-27.4%

Returns

ROE-129.2%
ROA—
ROIC (approx.)-176.5%
Asset turnover—

Leverage & solvency

Liabilities / assets67.5%
Debt / equity0.99x
Current ratio2.63x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.35x
Accruals ratio—
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31 · USDFY20242024-12-31 · USDFY20232023-12-31 · EURFY20222022-12-31 · EURFY20212021-12-31 · EUR
Income statement
Revenue$70.53M$69.39M60.42M55.11M44.06M
Cost of revenue$40.53M$40.65M36.01M30.92M25.64M
Gross profit$30.00M$28.74M24.41M24.19M18.42M
R&D expense$9.66M$8.36M6.96M4.92M3.40M
SG&A expense$17.72M$15.24M14.63M7.15M5.90M
Operating income-$24.69M-$22.23M-19.81M-4.26M-1.61M
Interest expense$789,000$256,000232,000168,00052,000
Pretax income-$28.81M-$20.27M-20.53M-2.10M893,000
Income tax$438,000$313,000644,000837,000193,000
Net income-$29.25M-$20.58M-21.18M-2.93M699,890
EBITDA-$21.29M-$19.45M-17.90M-2.65M308,000
EPS (basic)-0.78-0.55-0.57-0.090.02
EPS (diluted)-0.78-0.55-0.57-0.090.02
Weighted avg. shares (diluted)37.44M37.29M37.00M34.39M32.42M
Banking
Net interest income——1.08M236,000145,000
Balance sheet
Cash & equivalents$20.45M$31.00M43.47M63.14M47.18M
Short-term investments$00EUR000
Receivables$14.95M$19.32M17.86M13.42M10.86M
Inventory$7.77M$19.21M15.11M11.78M7.50M
Current assets$57.16M$72.59M78.48M90.52M67.38M
PP&E, net$8.79M$7.57M5.89M3.75M3.62M
Goodwill$757,000$2.50M2.41M2.41M2.41M
Intangibles$1.79M$1.13M1.08M725,000728,000
Total assets$79.00M$89.41M91.55M101.12M77.23M
Current liabilities$37.14M$39.28M27.60M21.71M17.95M
Short-term debt$2.08M$2.50M1.55M1.60M830,000
Long-term debt$15.90M$2.25M2.00M3.59M4.93M
Total debt$17.98M$4.75M3.55M5.19M5.76M
Total liabilities$59.58M$46.92M34.63M29.49M27.17M
Shareholders' equity$19.41M$42.48M56.92M71.63M50.05M
Net debt-$2.47M-$26.25M-39.92M-57.95M-41.42M
Shares outstanding37.48M37.39M37.10M36.91M33.47M
Cash flow statement
Operating cash flow-$16.41M-$14.70M-14.68M-3.02M4.45M
Investing cash flow-$5.71M-$4.46M-4.34M-2.38M-1.64M
Financing cash flow$8.61M$5.02M-911,00021.74M20.27M
Depreciation & amortization$3.41M$2.78M1.91M1.60M1.92M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· This company uses different currencies across periods or line items (e.g. USD convenience translations in annual reports). Each column header shows its currency and cells in a different currency are marked; do not compare figures across currencies. Charts use only periods in the latest period's currency.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.